The Israeli medical device company Exalenz Bioscience and the San Diego-based biotechnology company Conatus Pharmaceuticals will collaborate on a clinical trial for a chronic liver disease treatment.
The Japanese pharmaceutical company Takeda Pharmaceutical announced its new Access to Medicines strategy, which aims to increase patient access to the company’s gastroenterology and oncology medications.
The Los Angeles-based pharmaceutical development corporation Vitality Biopharma announced an expansion of its glycoside prodrug intellectual property portfolio.
The San Diego-based medical device company SpectraScience recently announced that their WavSTAT4 Optical Biopsy System technology has proven effective in the diagnosis of small colorectal cancer polyps.
More articles on GI company news:
Exalenz Bioscience, Conatus Pharmaceuticals collaborate on liver disease treatment: 5 notes
Takeda announces Access to Medicines strategy: 5 notes
Vitality Biopharma announces new patent filing for IBD pain relief: 4 notes
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
